The Jackson Laboratory, a large, unaffiliated US medical research group, expects to form a significant genomics collaboration with three groups in Wenzhou, a prefecture-level city in China’s southeastern Zhejiang province. In its first phase, the new collaboration will hire 75 to 100 employees and start genomics research collaborations with other organizations. In its second phase, the group would build labs in Wenzhou and hire an additional 300 to 500 employees. The Wenzhou collaboration will focus on genomic propensities for disease and will work to discover individualized therapies for cancer, heart disease and other afflictions.
